CVBF’s Researchers Unveil the Landscape of Paediatric Drug Research 2010-2023: An Analysis on Paediatric Post-Authorization Studies
A comprehensive analysis of paediatric Post-Authorization Studies (PAS) in the European Union has revealed significant insights into the landscape of drug [...]
CVBF’s CEO Donato Bonifazi presents at the 21st Global CardioVascular Clinical Trialists Forum
Donato Bonifazi, CEO of CVBF and Board Member of the Teddy European Network of Excellence for Paediatric Research, presented in the Global [...]
EU Health Summit 2025: Reshaping Health for a Stronger Europe
The EU Health Coalition, with CVBF as a proud member, invites you to the EU Health Summit on 28 January 2025, [...]
The Sharing and Reuse of Personal Data for Research Purpose under the GDPR
The European Joint Programme on Rare Diseases (EJP RD) "Innovative Therapies and Personalized Medicine for Rare Disease" Massive Open Online Course (MOOC), [...]
Biomarkers and Biosamples: Powering Precision Medicine for Rare Diseases
The European Joint Programme on Rare Diseases (EJP RD) "Innovative Therapies and Personalized Medicine for Rare Disease" Massive Open Online Course (MOOC), [...]
Understanding GDPR in Rare Disease Research: A Comprehensive Guide
In a comprehensive contribution to the EJP RD's Massive Open Online Course (MOOC) on "Innovative Therapies and Personalized Medicine for Rare [...]